Clinical Trial Update: To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males [Phase 1]

View source ↗

Summary

Phase 1 study to assess excretion balance and pharmacokinetics of a single oral dose of [14C]SB-681323 in healthy adult males.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SB-681323

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED